Anaplastic Ganglioglioma

Search Trials
SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
Status:
Recruiting
Last Changed:
Apr 4, 2022
First Changed:
Feb 15, 2018
Disease(s):
Anaplastic Astrocytoma
Intervention(s):
Gemcitabineribociclibsonidegibtrametinibfilgrastim
Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma
Status:
Recruiting
Last Changed:
May 9, 2022
First Changed:
Apr 18, 2019
Disease(s):
Anaplastic Astrocytoma
Intervention(s):
Dabrafenib MesylateRadiation TherapyTrametinib Dimethyl Sulfoxide
Pediatric Long-Term Follow-up and Rollover Study
Status:
Recruiting
Last Changed:
Apr 21, 2022
First Changed:
Jun 5, 2019
Disease(s):
Diffuse Astrocytoma
Intervention(s):
dabrafenibtrametinib
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Dec 21, 2021
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo

Connect. Empower. Inspire.